Maldives bans Aciloc injection batch over quality issues
It is manufactured by Kadila Pharmaceutical Limited (Ahmedabad) of India.
Maldives Food and Drug Authority (MFDA) on Tuesday banned the use of specific batches of imported injections due to quality issues.
According to the authority, quality issues have been found in batch number RP21311 of Aciloc (Ranitidine injections) imported and used in the Maldives.
The MFDA banned the import, sale and use of the batch number.
According to MFDA:
-
It is manufactured by Kadila Pharmaceutical Limited (Ahmedabad) of India
-
If the batch found to be causing the problem is located in any pharmacy or health care facility, it should be notified
-
Recently, cough syrups manufactured by an Indian pharmaceutical company were also banned in the country
Related
Related
Importing medicines without permit to carry fines of MVR 10,000
Pharmacies asked to stock 80% of essential medicines in 6 months
MFDA warns against weight-loss products with misleading claims
